Szymańska Beata, Marchewka Zofia, Knysz Brygida, Piwowar Agnieszka
Department of Toxicology, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, Poland.
Department of Infectious Diseases, Liver Diseases and Acquired Immune Deficiencies, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland.
Arch Med Sci. 2021 May 22;19(5):1289-1302. doi: 10.5114/aoms/114635. eCollection 2023.
For years, there has been an increase in the number of cases of chronic kidney disease (CKD) in human immunodeficiency virus (HIV)-infected patients. Renal dysfunction can be caused by direct effects of HIV on the kidneys but also of applied combined antiretroviral therapy (cART). Therefore there is a need of renal function diagnosis to monitor the development of kidney disturbances. In this study the urinary levels of selected low molecular weight proteins (LMWP) in HIV-infected patients were measured and related to current CD4+ T lymphocyte (LT CD4+) count, the glomerular filtration rate (eGFR) value and the applied cART.
The levels of 5 LMWP - kidney injury molecule-1 (KIM-1), neutrophil gelatinase associated lipocalin (NGAL), glutathione S-transferase α (GST-α) and π (GST-π) isoenzymes and neopterin (NPT) - in urine were measured in HIV-infected patients and healthy controls by enzyme-linked immunosorbent assay.
Taking into account the current LT CD4+ count, KIM-1, NGAL and GST-α showed statistically significant differences between groups with the CD4+ count < 500 and ≥ 500 cells (< 0.001). Depending on the eGFR, apart from KIM-1 and NGAL, NPT showed statistically significant differences in the investigated groups with normal and lower eGFR values (< 0.001). In terms of applied cART, the best parameters in the assessment of kidney damage were NGAL, GST-π and NPT (< 0.001).
This research shows that the analyzed LMWP parameters are useful in the assessment of kidney damage in HIV patients during cART, especially NPT, NGAL and GST-π. However, future studies should be conducted on larger groups.
多年来,人类免疫缺陷病毒(HIV)感染患者的慢性肾脏病(CKD)病例数一直在增加。肾功能障碍可能由HIV对肾脏的直接影响引起,也可能由应用的联合抗逆转录病毒疗法(cART)导致。因此,需要进行肾功能诊断以监测肾脏疾病的发展。在本研究中,测量了HIV感染患者尿液中选定的低分子量蛋白(LMWP)水平,并将其与当前的CD4 + T淋巴细胞(LT CD4 +)计数、肾小球滤过率(eGFR)值以及应用的cART相关联。
通过酶联免疫吸附测定法测量HIV感染患者和健康对照尿液中5种LMWP——肾损伤分子-1(KIM-1)、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、谷胱甘肽S-转移酶α(GST-α)和π(GST-π)同工酶以及新蝶呤(NPT)的水平。
考虑到当前的LT CD4 +计数,KIM-1、NGAL和GST-α在CD4 +计数<500和≥500细胞的组之间显示出统计学上的显著差异(<0.001)。根据eGFR,除了KIM-1和NGAL外,NPT在eGFR值正常和较低的研究组中显示出统计学上的显著差异(<0.001)。就应用的cART而言,评估肾脏损伤的最佳参数是NGAL、GST-π和NPT(<0.001)。
本研究表明,所分析的LMWP参数可用于评估HIV患者在cART期间的肾脏损伤,尤其是NPT、NGAL和GST-π。然而,未来应在更大的群体中进行研究。